Related Experiment Video
Updated: Jun 10, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Interleukins and cancer immunotherapy.
Takayuki Yoshimoto1, Noriko Morishima, Masae Okumura
1Intractable Disease Research Center, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan. yoshimot@tokyo-med.ac.jp
Immunotherapy
|July 20, 2010
Summary
New interleukins show promise for cancer immunotherapy by targeting tumors specifically. This approach may reduce side effects compared to traditional cancer treatments like chemotherapy and radiation.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Cancer involves complex interactions between normal and neoplastic cells.
- Current cancer therapies (chemotherapy, radiation) harm both cancerous and normal dividing cells, causing severe side effects.
- Immunotherapy offers a promising alternative by leveraging the host immune system to target tumors specifically, minimizing damage to healthy tissues.
Purpose of the Study:
- To review the antitumor effects of novel interleukins as potential agents for cancer immunotherapy.
- To highlight the promise of newly identified interleukins in augmenting the host immune response against tumors.
- To discuss the potential of these novel interleukins in improving cancer treatment efficacy and reducing side effects.
Main Methods:
- Review of scientific literature on cancer immunotherapy and interleukins.
- Analysis of studies investigating the antitumor properties of newly characterized interleukins.
- Synthesis of information regarding the mechanisms and clinical potential of these novel agents.
Main Results:
- Interleukins, particularly novel ones, demonstrate significant potential as cancer immunotherapy agents.
- These new interleukins may offer targeted antitumor effects with fewer side effects than conventional therapies.
- The identification and characterization of these novel interleukins are crucial for advancing cancer immunotherapy.
Conclusions:
- Novel interleukins represent a promising frontier in cancer immunotherapy.
- Targeted immunologic approaches using these interleukins could revolutionize cancer treatment.
- Further research into these novel interleukins is essential for their clinical application in combating cancer.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...